Progressive muscular atrophy (PMA) is a rare disease that affects lower motor neurons, brain cells that provide muscles and glands with the nerves needed to function correctly. People with this ...

A 14-year-old Asian young woman presented for a routine school physical examination with a 4-month history of an enlarging, nontender mass overlying her left scapula. She initially believed that ...

Epithelial basement membrane dystrophy (EBMD), also known as anterior basement membrane disease or map-dot-fingerprint dystrophy, is a common condition that affects the cornea of the eye (the clear, ...

The Supreme Court on Friday (October 25) permitted a candidate suffering from muscular dystrophy to participate in the ongoing counselling for NEET-UG 2024, considering that the expert report ...

However, one of those setters, Natalie Suffecool, was absent from Thursday’s Southwest Prairie Conference match against Joliet Central due to illness, leaving the setting duties in the hands of Peyton ...

Mouse model reveals liver involvement in muscular dystrophy. ScienceDaily . Retrieved November 15, 2024 from www.sciencedaily.com / releases / 2024 / 10 / 241024145510.htm ...

A new mouse model mimicking the liver symptoms of myotonic dystrophy type 1—the most prevalent form of adult-onset muscular dystrophy—provides insight into why patients develop fatty liver ...

Patients with Duchenne muscular dystrophy (DMD) have long been without effective treatment options. Longstanding treatments such as corticosteroids and exon-skipping therapies can prolong the time it ...

Becker muscular dystrophy (BMD), an X-linked muscular dystrophy, is mostly caused by an in-frame deletion of DMD. BMD severity varies from asymptomatic to severe, associated with the genotype of DMD.

Jefferies has initiated coverage of Sarepta Therapeutics (NASDAQ:SRPT) at buy saying its Duchenne muscular dystrophy franchise represents a $4B+ opportunity, as well as a strong pipeline and ...

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a ...